Garde Capital’s CVS Health CVS Stock Holding History

Garde Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,800	Closed	-$401K	–	261
2023 Q2	$401K	Buy	+5,800	New	+$413K	0.03%	161

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Garde Capital's CVS Position: Q3 2023 in Review

Garde Capital sold out of CVS Health (CVS) in Q3 2023, closing a stake of 5,800 shares — an estimated $401K sold.

Garde Capital first reported a position in CVS in Q2 2023 and held it in 1 quarter. The position peaked at $401K in Q2 2023. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

Garde Capital reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
Garde Capital sold 5,800 CVS Health shares in Q3 2023, an estimated $401K.
Garde Capital first reported a position in CVS Health in Q2 2023 and held it in 1 quarter.
Garde Capital's CVS Health position peaked at $401K in Q2 2023.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Garde Capital's 13F filing for Q3 2023, filed 17 Nov 2023.